Role of Hyperbaric Oxygen Therapy in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials

Abstract

Background

Traumatic brain injury (TBI) is a significant public health concern. Standard care involves conservative management and pharmacological and surgical interventions. Hyperbaric oxygen therapy (HBOT) has emerged as a potential treatment for TBI, with varied findings in the literature. Our systematic review aims to comprehensively assess the efficacy and safety of HBOT in TBI management, addressing existing knowledge gaps and providing insights for clinical practice and future research.

Materials and Methods

A systematic literature search was performed in PubMed, SCOPUS, Central Cochrane Registry of Controlled Trials (The Cochrane Library), and ScienceDirect databases for the role of HBOT in TBI. We included studies involving randomized controlled trials (RCTs). Quasi-randomized controlled studies, prospective, retrospective observational studies, case series, case reports, letters, editorials, comments, animal studies, and studies from non-English literature were excluded.

Results

After identifying 306 articles, we narrowed it to 8 for qualitative synthesis. The studies were categorized into subgroups: those on patients with an acute history of cerebral injury and those with a history of mild TBI. The combined RCTs involved 651 patients (326 in the first subgroup, 325 in the second). Despite a uniform HBOT session duration of 60 minutes, variations in compression, decompression phases, and pressure used (1.5ATA to 2.5ATA) hindered meta-analysis comparability. Outcome measures differed, complicating comparisons. Overall, HBOT appears beneficial in the first group and less so in the second. Complications are primarily pulmonary, which include dyspnea, cyanosis, hyperoxic pneumonia, and increased fraction of inspired oxygen requirement.

Conclusion

Our study encountered challenges in reaching definitive conclusions due to outcome variability among the included studies. Despite mixed results, HBOT shows potential benefits for acute TBI patients. Conversely, our findings suggest the limited efficacy of HBOT for chronic traumatic brain injury patients. Further research is crucial, particularly exploring diverse HBOT treatment protocols to establish optimal pressure levels and the required number of sessions for effective outcomes

Keywords

hyperbaric oxygen therapy - traumatic brain injury - posttraumatic stress disorder

Ethical Approval

The study was started after the approval from institutional ethical committee.

Publikationsverlauf

Artikel online veröffentlicht:
04. Juni 2024

• References

• 1 Rockswold SB, Rockswold GL, Zaun DA, Liu J. A prospective, randomized Phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, oxygen toxicity, and clinical outcome in severe traumatic brain injury. J Neurosurg 2013; 118 (06) 1317-1328
• 2 Liu H-y, Shang Y-h. Effect of guipizide maleate with hyperbaric oxygen therapy on neurophysiology and coagulation indices in patients with severe craniocerebral injury. Trop J Pharm Res 2023; 22 (07) 1483-1488
• 3 Konar S, Maurya I, Shukla DP. et al. Intensive care unit management of traumatic brain injury patients. Journal of Neurointensive Care. 2022; 5 (01) 1-8
• 4 Agrawal A, Savardekar A, Singh M. et al. Pattern of reporting and practices for the management of traumatic brain injury: an overview of published literature from India. Neurol India 2018; 66 (04) 976-1002
• 5 Hawryluk GWJ, Rubiano AM, Totten AM. et al. Guidelines for the management of severe traumatic brain injury: 2020 update of the decompressive craniectomy recommendations. Neurosurgery 2020; 87 (03) 427-434
• 6 Jha S, Ghewade P. Management and treatment of traumatic brain injuries. Cureus 2022; 14 (10) e30617
• 7 Vella MA, Crandall ML, Patel MB. Acute management of traumatic brain injury. Surg Clin North Am 2017; 97 (05) 1015-1030
• 8 Wang YH, Yang FY, Lian XY, Yang WJ. Effect of hyperbaric oxygen on the plasma endothelins in rats with severe head injury. Zhongguo Linchuang Kangfu 2004; 8 (01) 54-55
• 9 Hu SL, Hu R, Li F. et al. Hyperbaric oxygen preconditioning protects against traumatic brain injury at high altitude. Acta Neurochir Suppl (Wien) 2008; 105 (105) 191-196
• 10 Jin Z, Zhang ZJ, Bai Y. Intervention of hyperbaric oxygen treatment for the neuronal apoptosis and the expression of cyclooxygenase 2 in rats with head injury in an early period. Zhongguo Linchuang Kangfu 2006; 10 (38) 97-99
• 11 Artru F, Chacornac R, Deleuze R. Hyperbaric oxygenation for severe head injuries. Preliminary results of a controlled study. Eur Neurol 1976; 14 (04) 310-318
• 12 Cifu DX, Hart BB, West SL, Walker W, Carne W. The effect of hyperbaric oxygen on persistent postconcussion symptoms. J Head Trauma Rehabil 2014; 29 (01) 11-20
• 13 Ren B, Ye H, Shan W, Tao X, Ye Z. Effect of hyperbaric oxygen intervention on oxidative stress and expression of nerve growth factor in patients with craniocerebral injury. J Inflamm Res 2023; 16: 4925-4932
• 14 Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE. Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg 1992; 76 (06) 929-934
• 15 Walker JM, Mulatya C, Hebert D, Wilson SH, Lindblad AS, Weaver LK. Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post concussive mild traumatic brain injury compared to normal controls. Sleep Med 2018; 51: 66-79
• 16 Xie Z, Zhuang M, Lin L, Xu H, Chen L, Hu L. Changes of plasma C-reactive protein in patients with craniocerebral injury before and after hyperbaric oxygenation: a randomly controlled study. Neural Regen Res 2007; 2 (05) 314-317
• 17 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
• 18 Barker TH, Stone JC, Sears K. et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth 2023; 21 (03) 494-506
• 19 Barrett KF, Masel B, Patterson J, Scheibel RS, Corson KP, Mader JT. Regional CBF in chronic stable TBI treated with hyperbaric oxygen. Undersea Hyperb Med 2004; 31 (04) 395-406
• 20 Churchill S, Deru K, Weaver LK. et al. Adverse events and blinding in two randomized trials of hyperbaric oxygen for persistent post-concussive symptoms. Undersea Hyperb Med 2019; 46 (03) 331-340
• 21 Hu S, Li F, Luo H. et al. Amelioration of rCBF and PbtO2 following TBI at high altitude by hyperbaric oxygen pre-conditioning. Neurol Res 2010; 32 (02) 173-178
• 22 Mao JH, Sun ZS, Xiang Y. Observation of curative effects of hyperbaric oxygen for treatment on severe craniocerebral injury. J Clin Neurol 2010; 23 (05) 386-388
• 23 Nelson AG, Wolf Jr EG, Li B. Influence of delayed hyperbaric oxygenation on recovery from mechanically induced damage. Undersea & Hyperbaric Medicine 1994; 21 (02) 185-191
• 24 Rasmussen VM, Borgen AE, Jansen EC, Rotbøll Nielsen PH, Werner MU. Hyperbaric oxygen therapy attenuates central sensitization induced by a thermal injury in humans. Acta Anaesthesiol Scand 2015; 59 (06) 749-762
• 25 Wolf EG, Prye J, Michaelson R, Brower G, Profenna L, Boneta O. Hyperbaric side effects in a traumatic brain injury randomized clinical trial. Undersea Hyperb Med 2012; 39 (06) 1075-1082
• 26 Chawla A, Lavania AK. Oxygen toxicity. Med J Armed Forces India 2001; 57 (02) 131-133
• 27 Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) | ClinicalTrials.gov.
• 28 mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms | ClinicalTrials.gov.